CollPlant Biotechnologies Ltd

CLGN - CIK 0001631487

Market cap-

Rank-

SEC filings317

CLGN balance sheet (annual)

The table below shows CollPlant Biotechnologies Ltd's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & equivalents	$5.59M	$11.91M	$26.67M	$29.65M	$13.15M	$3.33M
Short-term investments	-	-	-	-	-	-
Receivables	$1.00K	$150.00K	$9.00K	$9.00K	$270.00K	$830.00K
Inventory	$573.00K	$440.00K	$714.00K	$1.43M	$1.08M	$1.26M

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.